REDIWIPES ANTISEPTIC CLEANING TOWELETTES- bzk antiseptic wipes swab 
Redicare LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

BZK Wipes

Active Ingredients...................................Uses

Benzalkonium Chloride 0.13%................................First Aid Antiseptic

Uses:

Antiseptic cleansing of face, hands and body to decrease bacteria on skin without soap and water. Antiseptic to help prevent further infection in minor cuts, scrapes, and burns.

Warnings

For external use only.

Do not use:

  • In the eyes. If this happens, rinse thoroughly with water.
  • Over large areas of the body
  • Longer than 1 week unless directed by a doctor

Stop use and ask doctor if:

  • Irritation of redness develop and persists for more than 72 hours.
  • the condition persists or gets worse

Keep out of reach of children:

If swallowed, get medical help or contact a Poison Control Center right away.

Ask a doctor before use if you have:

  • Deep or puncture wounds
  • Animal bites
  • Serious burns

Directions:

Tear open packet, unfold and use as a washcloth. Allow hands to dry without wiping.

Inactive Ingredients:

purified water, sodium bicarbonate

Other information:

BZK Wipe BoxPrincipal Display Panel for Packet

REDIWIPES ANTISEPTIC CLEANING TOWELETTES 
bzk antiseptic wipes swab
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:71105-323
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) BENZALKONIUM CHLORIDE0.13 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
SODIUM BICARBONATE (UNII: 8MDF5V39QO)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:71105-323-031 in 1 BOX03/31/2017
1NDC:71105-323-0225 in 1 PACKET
1NDC:71105-323-011.5 g in 1 PATCH; Type 2: Prefilled Drug Delivery Device/System (syringe, patch, etc.)
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart333A03/31/2017
Labeler - Redicare LLC (800149346)

Revised: 10/2022
Document Id: ead734a0-e691-a424-e053-2995a90aaa6b
Set id: 4aee9b2d-c669-4712-e054-00144ff8d46c
Version: 6
Effective Time: 20221012
 
Redicare LLC